Xiang Ling
Publications by Year
Research Areas
Cell death mechanisms and regulation, Nutritional Studies and Diet, Phagocytosis and Immune Regulation, Cancer therapeutics and mechanisms, Nanoplatforms for cancer theranostics
Most-Cited Works
- → Synthetic mRNA nanoparticle-mediated restoration of p53 tumor suppressor sensitizes p53 -deficient cancers to mTOR inhibition(2019)293 cited
- → B, N Codoped and Defect‐Rich Nanocarbon Material as a Metal‐Free Bifunctional Electrocatalyst for Oxygen Reduction and Evolution Reactions(2018)272 cited
- → Cancer therapeutics using survivin BIRC5 as a target: what can we do after over two decades of study?(2019)262 cited
- → Glutathione-Responsive Prodrug Nanoparticles for Effective Drug Delivery and Cancer Therapy(2018)257 cited
- → Engineering the Electronic Structure of MoS2 Nanorods by N and Mn Dopants for Ultra-Efficient Hydrogen Production(2018)236 cited
- Camptothecin (CPT) and its derivatives are known to target topoisomerase I (Top1) as their mechanism of action: did we miss something in CPT analogue molecular targets for treating human disease such as cancer?(2017)
- → Glutathione-Scavenging Poly(disulfide amide) Nanoparticles for the Effective Delivery of Pt(IV) Prodrugs and Reversal of Cisplatin Resistance(2018)207 cited
- → Survivin study: An update of “What is the next wave?”(2006)186 cited
- → Induction of Survivin Expression by Taxol (Paclitaxel) Is an Early Event, Which Is Independent of Taxol-mediated G2/M Arrest(2004)173 cited
- → Intracellular Fate of Nanoparticles with Polydopamine Surface Engineering and a Novel Strategy for Exocytosis-Inhibiting, Lysosome Impairment-Based Cancer Therapy(2017)172 cited